Source / episode info
- **Episode:**431
- **Title:**Divine Intervention Episode 431: USMLE Step 2CK/3 Rapid Review Series 89
- **Published:**2022-12-14
- Source:Episode page
One-liner
This episode provides a rapid review of key board topics including Graves' disease pathophysiology, the hematology of hereditary spherocytosis, the differential diagnosis and management of DI (SIADH vs CDI), drug-induced renal complications (cyclosporine toxicity, desmopressin effects), and endocrine risk factors for endometrial cancer.
High-yield summary
- Graves' Disease: Autoantibodies are TSH receptor agonists, leading to hyperthyroidism; the classic EKG finding is irregularly irregular rhythm (Atrial Fibrillation). Treatment mainstay is I-131 therapy.
- Hereditary Spherocytosis (HS): Caused by defects in cytoskeletal proteins (e.g., spectrin, ankyrin); leads to membrane instability and splenic destruction, resulting in hemolytic anemia and elevated indirect bilirubin.
- SIADH vs CDI: SIADH presents with hyponatremia and high urine osmolality; CDI presents with hypernatremia and low urine osmolality.
- Cyclosporine Toxicity: Can cause hypertension (via RAAS activation) and electrolyte abnormalities: Hyperkalemia (by suppressing aldosterone synthesis in the zona glomerulosa) and Type 4 RTA.
- PCOS & Endometrial Cancer: Chronic anovulation leads to unopposed estrogen exposure, increasing endometrial hyperplasia risk; obesity exacerbates this via increased aromatase activity in adipocytes.
Learning objectives
- Differentiate the pathophysiology and clinical presentation of primary vs secondary adrenal insufficiency (though not explicitly covered, this is a common trap).
- Interpret laboratory findings (TSH, T3/T4, bilirubin) to diagnose hyperthyroid states like Graves' disease.
- Correlate cytoskeletal protein defects with hemolytic anemias (e.g., Hereditary Spherocytosis).
- Master the differential diagnosis of hyponatremia based on urine osmolality and clinical history (SIADH vs CDI).
- Recognize drug-induced renal complications, specifically those associated with calcineurin inhibitors like cyclosporine.
Board exam buzzwords